Shares of Netherlands-based Orthofix International N.V. (NASDAQ:OFIX), a diversified global medical device company focused on developing and delivering innovative orthopedic solutions, have seen precipitous drop in price due to some company-specific issues and an unusual decline in Q1, 2013 gross margin. Currently the shares are trading around $20, near four-year lows.
Orthofix has a robust balance sheet, a unique product portfolio and a new management team, which I believe will help the company to stage a turnaround as early as next year. I believe that the correction offers an excellent investing opportunity for the medium-term with ~60% upside potential.
Orthofix is a diversified medical device company focused on developing and delivering innovative orthopedic solutions for patients,
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|